SEC asks CDSCO to submit adverse event report of death during Umifenovir trial
It should include analysis of the ethics committee, investigator and sponsor etc., for review
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Glenmark
Glenmark Pharmaceuticals gets ANDA approval for multiple sclerosis drug
Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (US FDA) for dimethyl…
HEAL Foundation organises Pharma Excellence Awards 2020
Pharma companies awarded for their exemplary work during COVID-19 crisis
Remdesivir and favipiravir price regulation required to safeguard patients’ interest in India:…
Both drugs have seen a sharp decline in price since the availability of the first generic in India
Glenmark announces top-line results from Phase 3 clinical trial of favipiravir for COVID-19…
The study evaluated the efficacy and safety of favipiravir plus standard supportive care, versus standard supportive care alone,…
FabiFlu more affordable than other drugs: Glenmark to DCGI
The company also sends its justifications and clarifications to allegations of false claims about FabiFlu’s use for COVID-19…
Glenmark set to get manufacturing and marketing approval for favipiravir
Sources inform that SEC has recommended the grant of permission, along with some recommendations, the company plans to launch its…
Seven success stories of LSSSDC’s partnerships to fight COVID-19
Zydus Cadila, Cadila Pharma, Biocon, Syngene, Glenmark, Serum Institute of India, Ipca, Strides are using LSSSDC’s programmes to…
Indian pharma companies looking to leverage opportunities in drug repurposing: GlobalData
In race for favipiravir clinical trials for COVID-19
Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India
Glenmark is the first company in India to initiate Phase 3 clinical trials on Favipiravir for COVID-19 patients in India